Recently, the p53-dependent chemo-resistance caused by CLB in CLL patients was shown to be reversed by some compounds from HDACIs, such as sodium butyrate and trichostatin A [22]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.